BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs6983267
,
VEGFA
,
Metabolism of xenobiotics
,
Lung cancer
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tetomilast
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Tetomilast: new promise for phosphodiesterase-4 inhibitors?
Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Tetomilast attenuates elastase-induced pulmonary emphysema through inhibition of oxidative stress in…
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammator…
Progress in PDE4 targeted therapy for inflammatory diseases].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) P…
A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ